Pfizer begins low-dose Covid vaccine trials in young children

With more than 144 million adults now fully vaccinated against Covid-19, Pfizer is moving ahead with low-dose trials in children under 12-years-old and could begin mass vaccinations of kids in the fall. NBC News’ Maura Barrett is in Jefferson, Louisiana, where doctors are testing whether the vaccine is safe for children.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting